Biotech R & D spending continues to rise

Nature Reviews Drug Discovery 16, 447 (2017). doi:10.1038/nrd.2017.130 Author: Asher Mullard Biotech R&D spending hit US$45.7 billion in 2016, up 12% from 2015, found an annual analysis of the sector by consulting firm EY (see Fig. 1). This was the seventh consecutive year that these firms increased their cumulative R&D spending, and the second consecutive
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: News and Analysis Source Type: research